A nucleic acid probe set comprising a) a first nucleic acid probe comprising i) an isolated nucleic acid having an overall length of not more than 40 nucleotides comprising a nuclectide sequence of SEQ ID NO: 344 or a complement thereof, wherein said nucleic acid is capable of hybridizing under selective stringency conditions to a human papillomavirus E6 gene, and optionally ii) a detectable label and/or ligand or wherein the nucleic acid is bound to a solid support, and b) a second nucleic acid probe comprising i) an isolated nucleic acid having an overall length of not more than 40 nucleotides comprising a nucleotide sequence selected from the group consisting of SEQ ID NO: 553 to SEQ ID NO: 556 and complements thereof, wherein said nucleic acid is capable of hybridizing under selective stringency conditions to a HPV L1 gene, and optionally ii) a detectable label and/or ligand or wherein the nucleic acid is bound to a solid support, wherein the first nucleic acid probe and the second nucleic acid probe are capable of hybridizing under stringent conditions to at least a portion of the same HPV genome, wherein the genome is a HPV2 genome, and wherein the first nucleic acid probe and the second nucleic acid probe are not capable of hybridizing under stringent conditions to the HPV genomes of HPV3, HPV6, HPV10, HPV11, HPV16, HPV18, HPV26, HPV27, HPV28, HPV29, HPV30, HPV31, HPV32, HPV33, HPV34, HPV35, HPV39, HPV42, HPV45, HPV51, HPV52, HPV53, HPV54, HPV56, HPV57, HPV58, HPV59, HPV64, HPV66, HPV67, HPV68, HPV69, HPV70, HPV73, HPV82, HPV84, HPV85, HPV86, HPV87, and HPV94. a) a first nucleic acid probe comprising i) an isolated nucleic acid having an overall length of not more than 40 nucleotides comprising a nuclectide sequence of SEQ ID NO: 344 or a complement thereof, wherein said nucleic acid is capable of hybridizing under selective stringency conditions to a human papillomavirus E6 gene, and optionally ii) a detectable label and/or ligand or wherein the nucleic acid is bound to a solid support, and i) an isolated nucleic acid having an overall length of not more than 40 nucleotides comprising a nuclectide sequence of SEQ ID NO: 344 or a complement thereof, wherein said nucleic acid is capable of hybridizing under selective stringency conditions to a human papillomavirus E6 gene, and optionally ii) a detectable label and/or ligand or wherein the nucleic acid is bound to a solid support, and b) a second nucleic acid probe comprising i) an isolated nucleic acid having an overall length of not more than 40 nucleotides comprising a nucleotide sequence selected from the group consisting of SEQ ID NO: 553 to SEQ ID NO: 556 and complements thereof, wherein said nucleic acid is capable of hybridizing under selective stringency conditions to a HPV L1 gene, and optionally ii) a detectable label and/or ligand or wherein the nucleic acid is bound to a solid support, i) an isolated nucleic acid having an overall length of not more than 40 nucleotides comprising a nucleotide sequence selected from the group consisting of SEQ ID NO: 553 to SEQ ID NO: 556 and complements thereof, wherein said nucleic acid is capable of hybridizing under selective stringency conditions to a HPV L1 gene, and optionally ii) a detectable label and/or ligand or wherein the nucleic acid is bound to a solid support,